Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XRF Scientific's revenue per share for the
six
months ended in Jun. 2026 was A$0.23.
XRF Scientific's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.45.
Warning Sign:
XRF Scientific Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of XRF Scientific was 5.70% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 3.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 13.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 12.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for XRF Scientific's Revenue per Share or its related term are showing as below:
ASX:XRF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -8.3 Med: 8.1 Max: 23
Current: 3.4
During the past 13 years, XRF Scientific's highest 3-Year average Revenue Per Share Growth Rate was 23.00% per year. The lowest was -8.30% per year. And the median was 8.10% per year.
ASX:XRF's 3-Year Revenue Growth Rate is ranked better than 50.19% of 522
companies
in the Conglomerates industry
Industry Median: 3.4
vs ASX:XRF: 3.40
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
XRF Scientific Revenue per Share Related Terms
XRF Scientific Revenue per Share Historical Data
* Premium members only.
The historical data trend for XRF Scientific's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific PS Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's PS Ratio distribution charts can be found below:
* The bar in red indicates where XRF Scientific's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
XRF Scientific's Revenue Per Share for the fiscal year that ended in Jun. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a Revenue per Share of A$0.45 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on XRF Scientific and its competitors. According to the industry distribution chart, XRF Scientific ranks #260 out of 522 companies in the Conglomerates industry, placing it in the top 49.8%.
Is XRF Scientific's Revenue per Share too high?
XRF Scientific's current Revenue per Share is A$0.45. Based on the distribution chart, XRF Scientific ranks #260 out of 522 companies in the Conglomerates industry, which is above the industry midpoint. Overall, XRF Scientific has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Revenue per Share compare to MMM and HON?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #260 out of 522 companies for Revenue per Share. This puts XRF Scientific in the upper half of its industry. The industry median Revenue per Share is 3.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Conglomerates company?
The median Revenue per Share among Conglomerates companies is 3.40, based on 522 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median Revenue per Share is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current Revenue per Share is A$0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.78, compared to a current price of A$1.82 — trading 2% above its estimated fair value. The current Revenue per Share is A$0.45. XRF Scientific's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Revenue per Share is A$0.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.82 is trading 2% above its estimated GF Value™ of A$1.78.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Revenue per Share: A$0.45
GF Value™: A$1.78 vs. price of A$1.82 (2% above fair value)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
96GF Score
Get the complete analysis for ASX:XRF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
